Zoetis Inc (ZTS) — Technical state
As of 2026-11-06 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Signal: Recovery attempt under the 200-day — Trades +5% vs the 50-day and -14% vs the 200-day average, 39.8% below the 52-week high and +15.5% off the 52-week low. Computed from daily closes. (as of 2026-11-06)
- Trend: Zoetis Inc trades 5.0% above its 50-day and 14.0% below its 200-day moving average. (as of 2026-11-06)
Zoetis discovers, makes and sells medicines, vaccines, diagnostics and other health products for animals, covering pets such as dogs, cats and horses as well as livestock like cattle, swine and poultry. Its range spans parasite treatments, vaccines, pain and infection drugs, diagnostic instruments and tests, and precision tools for farm management.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ZTS overview. Research diary readings, not advice.
Trades +5% vs the 50-day and -14% vs the 200-day average, 39.8% below the 52-week high and +15.5% off the 52-week low. Computed from daily closes.
The moving-average stack
- vs 20-day-0.3%
- vs 50-day+5%
- vs 200-day-14%
- 52-week band39.8% off the high · +15.5% off the low
- Streak2 consecutive down sessions
- 50-day crossprice crossed up through the 50-day 20 sessions ago
- Stochastic%K 22.6 · %D 77.6 · bear cross
Continue: the ZTS chart & overview · the signal board
FAQ · from the current data · as of 2026-11-06
Quick answers
What is the current Closelooknet signal on ZTS?
Recovery attempt under the 200-day — Trades +5% vs the 50-day and -14% vs the 200-day average, 39.8% below the 52-week high and +15.5% off the 52-week low. Computed from daily closes. As of 2026-11-06; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is ZTS above its 50-day and 200-day moving averages?
As of 2026-11-06, Zoetis Inc trades +5% above its 50-day and -14% below its 200-day average, with the 20-day -0.3% away.
How far is ZTS from its 52-week high?
39.8% below the 52-week high and 15.5% above the 52-week low, as of 2026-11-06.
Related in the Closelooknet universe
then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ROVI.MC Laboratorios Farmaceuticos ROVIindustry
- LNTH Lantheus Holdings Incindustry
- KNSA Kiniksa Pharmaceuticals Ltdindustry
- GALDY GALDERMA GROUP AGindustry
- ALM.MC Almirall S.A.industry
- FAGR.BR Fagron NVindustry
- XERS Xeris Pharmaceuticals Incindustry
- PCRX Pacira BioSciences, Inc.industry
- HLUN-B.CO H Lundbeck A/Sindustry
- VETO.PA Vetoquinolindustry
- VTRS Viatris Incindustry
- AMPH Amphastar Pindustry
- IRWD Ironwood Pharmaceuticals Incindustry
- NBIX Neurocrine Biosciences Incindustry
- ELAN Elanco Animal Healthindustry
- HCM HUTCHMED DRCindustry
- CRON Cronos Group Incindustry
- GUD.TO Knight Therapeutics Inc.industry
- 000538.SHE Yunnan Baiyao Group Co Ltdindustry
- DHT-UN.TO DRI Healthcare Trustindustry